hVIVO Employee Directory
Biotechnology ResearchEngland, United Kingdom201-500 Employees
hVIVO is a mid-sized biotechnology firm based in London, England, focused on early‑phase drug development. It operates an integrated ecosystem that combines specialist clinical sites, virology and immunology laboratories, human challenge expertise, and early drug development consulting to generate rigorous human data earlier in development. This approach helps sponsors reduce uncertainty and accelerate progression through Phase I and II trials. The company concentrates on respiratory and infectious diseases, with expanding capabilities in cardiometabolic and other high-growth therapeutic areas, serving a global client base that includes several of the world’s largest biopharmaceutical companies. Its London facilities include purpose‑built human challenge units that are among the largest globally, complemented by additional early‑phase capacity in Germany and a dedicated consulting team providing regulatory and biometry expertise. hVIVO presents an integrated path from preclinical planning to early proof‑of‑concept, supported by continuous patient recruitment through FluCamp and a network of outpatient sites for later-stage studies.